Publication | Open Access
The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers
182
Citations
0
References
2002
Year
Enoxaparin was well tolerated when administered subcutaneously or intravenously, and there appears to be no need to modify the currently recommended dose for obese volunteers.